<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04253301</url>
  </required_header>
  <id_info>
    <org_study_id>IM-CP-2001</org_study_id>
    <nct_id>NCT04253301</nct_id>
  </id_info>
  <brief_title>Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency</brief_title>
  <official_title>Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InnoVein</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InnoVein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This objective of this feasibility study is to evaluate the safety of the InnoVein Valve and&#xD;
      Delivery System for treatment of chronic venous insufficiency.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic Venous Insufficiency occurs when the venous wall and/or valves in the leg veins are&#xD;
      not working effectively, making it difficult for blood to return to the heart from the&#xD;
      legs.The core etiology of the disease stems from increased venous pressure and incompetent&#xD;
      venous valves leading to regurgitation of blood that accumulates in the legs. It has been&#xD;
      shown that implantation or recreation of a functional valve can lead to clearance of excess&#xD;
      blood and resolution of symptoms.&#xD;
&#xD;
      The InnoVein Valve and Delivery System is a new, investigational biocompatible valve intended&#xD;
      to support natural flow in vessels in patients with Chronic Venous Insufficiency. The purpose&#xD;
      of this study is to assess the safety of the InnoVein Valve and Delivery System for treatment&#xD;
      of Chronic Venous Insufficiency.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2020</start_date>
  <completion_date type="Anticipated">January 15, 2027</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of the InnoVein Valve and Delivery System: Number of Major Adverse Events</measure>
    <time_frame>30 Days</time_frame>
    <description>Number of Major Adverse Events</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Chronic Venous Insufficiency</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will have the InnoVein Valve implanted</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>InnoVein Valve Treatment</intervention_name>
    <description>Subjects will have the InnoVein Valve implanted</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Willing and able to provide written Informed Consent&#xD;
&#xD;
          -  Diagnosis of symptomatic non-obstructive chronic valvular insufficiency of the femoral&#xD;
             vein&#xD;
&#xD;
          -  Willing and medically able to receive intraprocedural and post-procedural&#xD;
             anticoagulation medication&#xD;
&#xD;
          -  Life expectancy &gt;1yr&#xD;
&#xD;
          -  Reflux time &gt;1s in the superficial femoral and/or popliteal vein&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Any prior deep vein intervention within 6 months prior to the Index Procedure&#xD;
&#xD;
          -  History of 2+ DVTs&#xD;
&#xD;
          -  Inadequate inflow to the femoral vein or inadequate outflow through the femoral vein,&#xD;
             iliac vein, or IVC&#xD;
&#xD;
          -  Current IVC Placement&#xD;
&#xD;
          -  History of pulmonary embolism within 6 months&#xD;
&#xD;
          -  Conditions that increase the risk of device thrombosis or patient bleeding&#xD;
&#xD;
          -  Any planned surgical or interventional procedure within 30 days prior to or after the&#xD;
             Index Procedure&#xD;
&#xD;
          -  Investigator or sponsor believes the subject would not benefit, would not be&#xD;
             appropriate, be unable to follow-up, or be at high risk for non-compliance with the&#xD;
             protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>InnoVen Data Management</last_name>
    <phone>650-302-0847</phone>
    <email>IM-CP-2001@innoveinmedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hollywood Private Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krys Hiscock, RN</last_name>
      <phone>0474 769 593</phone>
      <email>nursing@affinityresearch.com.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Jansen, MD</last_name>
      <phone>+61 8 6151 0820</phone>
      <email>JShirley.Jansen@health.wa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flinders</name>
      <address>
        <city>Adelaide</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Toomey</last_name>
      <phone>08 82045445</phone>
      <email>Melanie.Toomey@sa.gov.au</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 31, 2020</study_first_submitted>
  <study_first_submitted_qc>January 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Venous Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

